US Stock MarketDetailed Quotes
VTVT vTv Therapeutics
- 15.0300
- -0.6700-4.27%
Close Dec 13 16:00 ET
- 15.0300
- 0.00000.00%
Post 20:01 ET
39.26MMarket Cap-3.44P/E (TTM)
15.4700High14.8600Low7.76KVolume15.0800Open15.7000Pre Close117.58KTurnover0.73%Turnover RatioLossP/E (Static)2.61MShares30.990052wk High2.62P/B15.98MFloat Cap7.380052wk Low--Dividend TTM1.06MShs Float560.0000Historical High--Div YieldTTM3.89%Amplitude7.3800Historical Low15.1600Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
vTv Therapeutics Stock Forum
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER
Monday, 9th December at 7:33 am
WESTON, Fla., Dec. 9, 2024 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions, announced today that the U.S. Food and Drug Administration (FDA) granted Orphan Drug D...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER
$Clearmind Medicine (CMND.US)$ 1st
$Aditxt (ADTX.US)$ 2nd
$SciSparc (SPRC.US)$ 3rd
$Ampio Pharmaceuticals (AMPE.US)$ 4th
$Motus GI (MOTS.US)$ 5th
$vTv Therapeutics (VTVT.US)$ 6th
Top spac watch
$PROOF Acquisition Corp. I (PACI.US)$ 1st
$HNR Acquisition Corp (HNRA.US)$ 2nd
$Innovative International Acquisition Corp (IOAC.US)$ 3rd
$10X Capital Venture Acquisition Corp. II (VCXA.US)$ 4th ...
$Jeffs' Brands (JFBR.US)$
$Clearmind Medicine (CMND.US)$
$SciSparc (SPRC.US)$
$Yoshiharu Global (YOSH.US)$
$Aditxt (ADTX.US)$
$Cemtrex (CETX.US)$
$HNR Acquisition Corp (HNRA.US)$
$Ampio Pharmaceuticals (AMPE.US)$
$Cingulate (CING.US)$
$Motus GI (MOTS.US)$
No comment yet